What to expect at the BD&L Summit
Unlock the potential of a deal through optimized business development activities and transactional excellence to drive a company's competitive position in today's marketplace.
With the ROI for pharma R&D dwindling in recent years, business development and partnering opportunities have become an attractive strategy to bolster fledgling product pipelines and de-risk the development of new products. In order to ensure that every potential for unlocking the value of a transaction has been realized, life science companies need to ensure the right internal experts are involved in the evaluation process. This calls for the development and continuous improvement of a formal process that will allow organizations to efficiently and effectively evaluate, negotiate, and structure a transaction.
The BD&L Summit for Life Sciences will provide an overview of the industry’s most recent trends, and will feature the proven strategies and insights of leaders from biotech, mid-sized, and large pharmaceutical companies on successfully managing business development, M&A, strategic alliance, and licensing activities.
Who Attends
This conference attracts SVPs, VPs, Directors, Heads and Managers from the pharmaceutical, biotechnology, and medical device industries whose responsibilities include:
Business Development |
Mergers and Acquisitions |
Licensing |
Strategic Alliance/Alliance Management |
Intellectual Property and Patent Counsel |
Search and Evaluation |
Due Diligence |
External Innovation |
Transactions |
Portfolio Management |
Scientific Assessment |
General Counsel/Corporate Counsel |
Legal and Regulatory Compliance |
Regulatory Affairs |
Research and Development |
Clinical Medicine |
Clinical Operations |
Life Cycle Management |
Past Participants of BD&L Summit Include
Abbott |
Acadia |
Allergan |
Amgen |
Arcus Biosciences |
Astellas |
Bayer |
BeiGene |
BioMarin |
Boehringer Ingelheim |
Daiichi Sankyo |
Eli Lilly |
Genentech |
Heron Therapeutics |
Janssen |
Kaleo Pharma |
Mallinckrodt |
Merck |
Myovant Sciences |
Samumed |
Sanofi |
Theravance BioPharma |
Vertex |
|